|

Bojungikki-tang(BJIKT) Clinical Trials

1 actively recruiting trial

Also known as: Buzhong Yiqi Decoction, Hochu-ekki-to

Pipeline

Phase 2: 1

Top Sponsors

  • Korea Institute of Oriental Medicine1

Indications

  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.